首頁 > 市場調查報告書 > 食物/飲料

市場調查報告書

商品編碼

1984881

全球微藻生物技術市場：依應用、產品類型、終端用戶和技術劃分－全球產業分析、市場規模、趨勢、主要參與者、區域展望及預測（2025-2035）

Global Microalgae Biotechnology Market: By Application, Product Type, End User, Technology, - Global Industry Analysis, Size, Trends, Leading Companies, Regional Outlook, and Forecast 2025 to 2035

出版日期: 2026年01月22日 | 出版商:

Astute Analytica | 英文 | 商品交期: 最快1-2個工作天內

價格

簡介目錄

全球微藻生物技術市場正經歷重大變革，反映出其在眾多產業中日益增長的重要性。 2025年，該市場規模約為39億美元，預計將快速成長，到2035年將超過102.1億美元。在2026-2035年的預測期內，該市場將以約10.1%的複合年增長率成長。如此強勁的成長是由幾個關鍵因素驅動的，這些因素正在改變微藻應用和生產技術的模式。

其中一個關鍵的成長驅動因素是對高價值藻類衍生成分日益增長的需求。這包括一些特殊化合物，例如ω-3脂肪酸、色素、抗氧化劑和生物活性分子，它們在醫藥、營養保健品、化妝品和功能性食品等廣泛領域都有應用。高昂的價格以及消費者對天然和永續成分日益增長的偏好正在推動該領域的投資和創新。

主要市場趨勢

微藻生物技術市場呈現出獨特的結構，主要參與者之間存在適度的整合，而基層企業則高度分散。這種雙重性既反映了成熟產業巨頭的存在，也反映了由中小企業、新創公司和利基創新者組成的多元化市場環境。在旨在整合能力、拓展產品組合和加速技術進步的併購和策略聯盟浪潮的推動下，市場正經歷著快速轉型。

在主要參與者中，DIC 公司憑藉其 "Earthrise Nutritionals" 品牌，已確立了其在螺旋藻生產領域不可撼動的領導地位。 DIC 總部位於日本，利用其位於加利福尼亞州和中國的戰略性大型養殖設施，高效地供應全球市場。其競爭優勢源自於數十年來在大規模微藻養殖、品質控制和供應鏈管理方面的經驗和專業知識。 Earthrise Nutritionals 以其一致的高品質螺旋藻產品而聞名，這些產品廣泛應用於膳食補充劑和功能性食品等領域。市場上另一家重要的參與者是帝斯曼-菲美意公司，該公司是 omega-3 脂肪酸領域的領導者。該公司專注於利用裂殖壺菌微藻透過吞噬發酵生產EPA和DHA這兩種關鍵的ω-3脂肪酸成分。這種創新方法繞過了傳統的海洋來源，例如魚油，而魚油正面臨著來自永續性和供應限制方面的日益嚴格的審查。透過利用發酵技術，帝斯曼-菲美尼希正在革新傳統的魚油市場，提供一種可擴展、可持續且高純度的替代方案，以滿足食品、藥品和膳食補充劑領域對植物性ω-3脂肪酸日益增長的需求。

主要成長驅動因素

全球 "蛋白質轉化" 正成為微藻生物技術市場成長的關鍵驅動因素。預計到2050年，世界人口將達到約97億，傳統農業系統正面臨滿足日益增長的蛋白質需求的巨大壓力。傳統的蛋白質生產方式，特別是畜牧業，不僅消耗大量資源，還會帶來嚴重的生態風險，包括森林砍伐、溫室氣體排放和淡水過度消耗。這些環境挑戰凸顯了迫切需要可持續的替代方案，以便在不進一步破壞地球生態系統的前提下，提供充足且營養豐富的蛋白質。

新興機會

微藻生物技術的一個新前沿領域是 "客製化藻類" 的開發，這些藻類是透過基因工程改造的，旨在增強特定特性並提高生產效率。與傳統藻類不同，這些客製化藻類經過改造，可以顯著提高產量或直接生產有用的化合物，具有革新該行業的潛力。雖然歐盟等地區對基因改造生物（GMO）的監管架構仍然嚴格，但基因改造微藻正在美國和亞洲部分地區的生物技術領域逐漸被接受。

優化障礙

雖然微藻可以利用陽光和簡單的營養物質生長，使其培養成本相對較低，但下游製程有許多挑戰，可能會阻礙整體市場成長。微藻的收穫、脫水和乾燥都是能源密集且成本高昂的工藝，通常佔總生產成本的30%之多。高成本源自於微藻細胞漂浮在大量水中，使得分離和濃縮過程複雜且資源消耗龐大。

產業價值鏈分析
- 原料及零件供應商
- 製造商
- 經銷商
- 終端用戶
行業展望
- 全球飼料統計數據
PESTLE 分析
波特五力分析
- 供應商議價能力
- 買方議價能力
- 替代品威脅
- 新進入者威脅
- 競爭強度
市場成長與展望
- 市場收入估計與預測（2020-2035）
- 價格趨勢分析

第四章全球微藻生物技術市場分析

競爭格局概覽
- 市場集中度比
- 公司佔有率分析（價值，%），2025 年
- 競爭對手分析與基準分析

第五章全球微藻生物技術市場分析

市場動態與趨勢
- 成長驅動因素
- 限制因素
- 機遇
- 主要趨勢
市場規模及預測（2020-2035 年）
- 依產品類型劃分
- 依應用程式劃分
- 依技術劃分
- 依最終用戶劃分
- 依地區劃分

第六章北美微藻生物技術市場分析

第七章歐洲微藻生物技術市場

分析

第八章：亞太地區微藻生物技術市場分析

第九章：中東與非洲微藻生物技術市場分析

第十章：南美洲微藻生物技術市場分析

第十一章：公司簡介

AlgaEnergy S.A.
Algatech Ltd.
Algenol Biofuels Inc.
Allmicroalgae-Natural Products S.A.
AstaReal AB
BlueBioTech Int. GmbH
Cellana Inc.
Corbion N.V.
Cyanotech Corporation
DIC Corporation
E.I.D. Parry (India) Limited
富士化學工業株式會社
Heliae Development, LLC
MicroBio Engineering, Inc.
Necton S.A.
Parry Nutraceuticals
Phycom Microalgae
Roquette KlA¶tze GmbH &Co. KG
Seambiotic Ltd.
Solazyme (TerraVia Holdings, Inc.)
其他主要參與者

第十二章附錄

簡介目錄

Product Code: AA01261680

The global microalgae biotechnology market is undergoing a significant transformation, reflecting its growing importance across multiple industries. Valued at approximately USD 3.9 billion in 2025, the market is projected to expand rapidly, surpassing USD 10.21 billion by 2035. This growth corresponds to a compound annual growth rate (CAGR) of around 10.1% during the forecast period from 2026 to 2035. Such robust expansion is driven by several key factors that are reshaping the landscape of microalgae applications and production technologies.

One of the primary growth drivers is the increasing demand for high-value algal derivatives. These include specialized compounds such as omega-3 fatty acids, pigments, antioxidants, and bioactive molecules that have wide-ranging applications in pharmaceuticals, nutraceuticals, cosmetics, and functional foods. The premium pricing and growing consumer preference for natural, sustainable ingredients are fueling investments and innovation in this sector.

Noteworthy Market Developments

The microalgae biotechnology market exhibits a unique structure characterized by moderate consolidation among leading companies, while remaining highly fragmented at the lower tiers. This dual nature reflects both the presence of established industry giants and a diverse landscape of smaller players, startups, and niche innovators. The market is undergoing rapid transformation, driven by a wave of mergers, acquisitions, and strategic partnerships that aim to consolidate capabilities, expand product portfolios, and accelerate technological advancement.

Among the top players, DIC Corporation, operating under the brand Earthrise Nutritionals, stands as the undisputed leader in Spirulina production. Headquartered in Japan, DIC leverages massive cultivation facilities strategically located in California and China, enabling them to serve global markets efficiently. Their dominance is rooted in decades of experience and expertise in large-scale microalgae cultivation, quality control, and supply chain management. Earthrise Nutritionals has built a reputation for consistent, high-quality Spirulina products that cater to diverse applications ranging from dietary supplements to functional foods.

Another major force in the market is DSM-Firmenich, a powerhouse in the Omega-3 fatty acids sector. They specialize in producing EPA and DHA-two critical Omega-3 compounds-using Schizochytrium microalgae through heterotrophic fermentation. This innovative approach bypasses traditional marine sources such as fish oil, which are increasingly scrutinized for sustainability and supply constraints. By harnessing fermentation technology, DSM-Firmenich is disrupting the conventional fish oil market, offering a scalable, sustainable, and high-purity alternative that meets the growing demand for plant-based Omega-3 ingredients in food, pharmaceuticals, and nutraceuticals.

Core Growth Drivers

The global protein transition is emerging as a critical driver of growth in the microalgae biotechnology market. With the world's population projected to reach approximately 9.7 billion by 2050, traditional agricultural systems face immense pressure to meet escalating protein demands. Conventional protein production methods, particularly livestock farming, are not only resource-intensive but also pose severe ecological risks, including deforestation, greenhouse gas emissions, and excessive freshwater use. These environmental challenges highlight the urgent need for sustainable alternatives that can provide sufficient, nutritious protein without further degrading the planet's ecosystems.

Emerging Opportunity Trends

The emerging frontier in microalgae biotechnology is the development of "designer algae," genetically engineered strains tailored to enhance specific traits and improve production efficiency. Unlike traditional strains, these designer algae are modified to deliver significantly higher yields or produce valuable compounds directly, offering transformative potential for the industry. While regulatory frameworks surrounding genetically modified organisms (GMOs) remain stringent in regions like the European Union, the markets in the United States and parts of Asia are progressively embracing genetically modified microalgae within their biotechnology sectors.

Barriers to Optimization

While cultivating microalgae is relatively inexpensive due to their ability to grow using sunlight and simple nutrients, the downstream processing stages present significant challenges that could hamper overall market growth. Harvesting, dewatering, and drying microalgae are particularly energy-intensive and costly steps, often accounting for up to 30% of the total production costs. This high expenditure arises because microalgae cells are suspended in large volumes of water, making their separation and concentration a complex and resource-demanding process.

Detailed Market Segmentation

By Product Type, in 2025, the Microalgae Biomass segment held the largest share of the microalgae biotechnology market, accounting for 38.95% of the total. This prominence is largely due to the economic advantages of selling whole-cell biomass compared to the costly downstream extraction processes required to isolate specific compounds. Techniques such as supercritical CO2 extraction, while effective for obtaining oils and other high-value components, involve complex, multi-step procedures that significantly increase production costs. By marketing whole microalgae biomass directly, producers can bypass these expensive extraction steps, reducing both capital and operational expenditures.

By Technology Type, in 2025, the Cultivation Open Pond Systems segment dominated the microalgae biotechnology market by securing the largest share, accounting for 48.52% of the total market. This leadership position highlights the continued preference for open pond systems as a cost-effective and efficient technology for cultivating microalgae. One of the primary reasons for their widespread use is the significantly lower capital and operational costs compared to alternative technologies such as Closed Photobioreactors (PBRs).

By End-User, the Pharmaceutical and Biotechnology Companies segment represents the largest end-user group, holding a commanding 42% share of the market. This significant market presence reflects a broader shift in how microalgae are perceived and utilized, marking a transition from being viewed merely as traditional agricultural commodities to becoming advanced, high-value biotech ingredients. The evolution of microalgae applications into sophisticated therapeutic and biotechnological tools highlights the growing recognition of their potential within cutting-edge scientific fields.

By application, the pharmaceuticals and nutraceuticals segment commands the largest share, accounting for 37.23% of the market. This dominance is closely tied to the nature of modern biotechnology, which requires substantial capital expenditures (CAPEX) for development, production, and regulatory compliance. The high costs associated with these advanced technologies necessitate significant profit margins to justify investment and sustain innovation. As a result, sectors that offer the highest return on investment naturally rise to prominence.

Segment Breakdown

By Product Type

Microalgae Biomass
Pigments & Colorants
Astaxanthin
Beta-Carotene
Phycocyanin
Others
Omega-3 Fatty Acids
Proteins & Peptides
Bioactive Compounds & Antioxidants
Biofuels
Biodiesel
Bioethanol
Biogas
Others

By Application

Pharmaceuticals & Nutraceuticals
Cosmetics & Personal Care
Biofuels & Renewable Energy
Agriculture & Animal Feed
Wastewater Treatment & Environmental Management
Food & Beverages
Others

By Technology

Cultivation & Growth Technologies
Open Pond Systems
Photobioreactors (PBRs)
Hybrid Systems
Downstream Processing
Harvesting & Dewatering
Extraction & Purification
Formulation

By End User

Pharmaceutical & Biotechnology Companies
Food & Nutraceutical Manufacturers
Cosmetic & Personal Care Companies
Biofuel Producers
Agriculture & Animal Feed Companies
Environmental Services & Wastewater Treatment
Research & Academic Institutes

By Region

North America
Europe
Asia Pacific
Middle East and Africa
South America

Geography Breakdown

North America stands out as the primary innovation engine and a high-value consumer hub within the global microalgae biotechnology market, commanding control over more than 43% of the market share. This leadership is especially pronounced in the United States, where the industry has undergone a remarkable transformation. After experiencing the setback of the "algae-for-fuel" failure in the 2010s, the region successfully shifted its focus toward a more refined and sophisticated "precision biology" approach. This new model emphasizes the development and commercialization of specialized, high-value derivatives extracted from microalgae, rather than relying on the sheer volume of raw biomass.

By 2024, North America's microalgae biotechnology market will contribute approximately $1.12 billion to the global revenue, underscoring the region's dominance. This substantial figure is driven primarily by the premium pricing associated with pharmaceutical-grade algae products, which command significantly higher values compared to bulk biomass sales. The emphasis on quality, targeted applications, and advanced biotechnological processes has allowed North America to position itself as a leader in producing highly specialized algae-based products.

Leading Market Participants

AlgaEnergy S.A.
Algatech Ltd.
Algenol Biofuels Inc.
Allmicroalgae - Natural Products S.A.
AstaReal AB
BlueBioTech Int. GmbH
Cellana Inc.
Corbion N.V.
Cyanotech Corporation
DIC Corporation
E.I.D. Parry (India) Limited
Fuji Chemical Industries Co., Ltd.
Heliae Development, LLC
MicroBio Engineering, Inc.
Necton S.A.
Parry Nutraceuticals
Phycom Microalgae
Roquette KlA¶tze GmbH & Co. KG
Seambiotic Ltd.
Solazyme (TerraVia Holdings, Inc.)
Other Prominent Players

Table of Content

Chapter 1. Executive Summary: Global Microalgae Biotechnology Market

Chapter 2. Research Methodology & Research Framework

2.1. Research Objective
2.2. Product Overview
2.3. Market Segmentation
2.4. Qualitative Research
- 2.4.1. Primary & Secondary Source
2.5. Quantitative Research
- 2.5.1. Primary & Secondary Source
2.6. Breakdown of Primary Research Respondents, By Region
2.7. Assumption for Study
2.8. Market Size Estimation
2.9. Data Triangulation

Chapter 3. Global Microalgae Biotechnology Market Overview

3.1. Industry Value Chain Analysis
- 3.1.1. Raw Material/Component Provider
- 3.1.2. Manufacturer
- 3.1.3. Distributor
- 3.1.4. End User
3.2. Industry Outlook
- 3.2.1. Global Feed Statistics
3.3. PESTLE Analysis
3.4. Porter's Five Forces Analysis
- 3.4.1. Bargaining Power of Suppliers
- 3.4.2. Bargaining Power of Buyers
- 3.4.3. Threat of Substitutes
- 3.4.4. Threat of New Entrants
- 3.4.5. Degree of Competition
3.5. Market Growth and Outlook
- 3.5.1. Market Revenue Estimates and Forecast (US$ Mn), 2020-2035
- 3.5.2. Price Trend Analysis

Chapter 4. Global Microalgae Biotechnology Market Analysis

4.1. Competition Dashboard
- 4.1.1. Market Concentration Rate
- 4.1.2. Company Market Share Analysis (Value %), 2025
- 4.1.3. Competitor Mapping & Benchmarking

Chapter 5. Global Microalgae Biotechnology Market Analysis

5.1. Market Dynamics and Trends
- 5.1.1. Growth Drivers
- 5.1.2. Restraints
- 5.1.3. Opportunity
- 5.1.4. Key Trends
5.2. Market Size and Forecast, 2020-2035 (US$ Mn)
- 5.2.1. By Product Type
  - 5.2.1.1. Key Insights
    - 5.2.1.1.1. Microalgae Biomass
    - 5.2.1.1.2. Pigments & Colorants
      - 5.2.1.1.2.1. Astaxanthin
      - 5.2.1.1.2.2. Beta-Carotene
      - 5.2.1.1.2.3. Phycocyanin
      - 5.2.1.1.2.4. Others
    - 5.2.1.1.3. Omega-3 Fatty Acids
    - 5.2.1.1.4. Proteins & Peptides
    - 5.2.1.1.5. Bioactive Compounds & Antioxidants
      - 5.2.1.1.5.1. Biofuels
      - 5.2.1.1.5.2. Biodiesel
      - 5.2.1.1.5.3. Bioethanol
      - 5.2.1.1.5.4. Biogas
      - 5.2.1.1.5.5. Others
- 5.2.2. By Application
  - 5.2.2.1. Key Insights
    - 5.2.2.1.1. Pharmaceuticals & Nutraceuticals
    - 5.2.2.1.2. Cosmetics & Personal Care
    - 5.2.2.1.3. Biofuels & Renewable Energy
    - 5.2.2.1.4. Agriculture & Animal Feed
    - 5.2.2.1.5. Wastewater Treatment & Environmental Management
    - 5.2.2.1.6. Food & Beverages
    - 5.2.2.1.7. Others
- 5.2.3. By Technology
  - 5.2.3.1. Key Insights
    - 5.2.3.1.1. Cultivation & Growth Technologies
    - 5.2.3.1.2. Open Pond Systems
    - 5.2.3.1.3. Photobioreactors (PBRs)
    - 5.2.3.1.4. Hybrid Systems
    - 5.2.3.1.5. Downstream Processing
    - 5.2.3.1.6. Harvesting & Dewatering
    - 5.2.3.1.7. Extraction & Purification
    - 5.2.3.1.8. Formulation
- 5.2.4. By End User
  - 5.2.4.1. Key Insights
    - 5.2.4.1.1. Pharmaceutical & Biotechnology Companies
    - 5.2.4.1.2. Food & Nutraceutical Manufacturers
    - 5.2.4.1.3. Cosmetic & Personal Care Companies
    - 5.2.4.1.4. Biofuel Producers
    - 5.2.4.1.5. Agriculture & Animal Feed Companies
    - 5.2.4.1.6. Environmental Services & Wastewater Treatment
    - 5.2.4.1.7. Research & Academic Institutes
- 5.2.5. By Region
  - 5.2.5.1. Key Insights
    - 5.2.5.1.1. North America
      - 5.2.5.1.1.1. The U.S.
      - 5.2.5.1.1.2. Canada
      - 5.2.5.1.1.3. Mexico
    - 5.2.5.1.2. Europe
      - 5.2.5.1.2.1. Western Europe
        
        5.2.5.1.2.1.1. The UK
        5.2.5.1.2.1.2. Germany
        5.2.5.1.2.1.3. France
        5.2.5.1.2.1.4. Italy
        5.2.5.1.2.1.5. Spain
        5.2.5.1.2.1.6. Rest of Western Europe
      - 5.2.5.1.2.2. Eastern Europe
        
        5.2.5.1.2.2.1. Poland
        5.2.5.1.2.2.2. Russia
        5.2.5.1.2.2.3. Rest of Eastern Europe
    - 5.2.5.1.3. Asia Pacific
      - 5.2.5.1.3.1. China
      - 5.2.5.1.3.2. India
      - 5.2.5.1.3.3. Japan
      - 5.2.5.1.3.4. South Korea
      - 5.2.5.1.3.5. Australia & New Zealand
      - 5.2.5.1.3.6. ASEAN
      - 5.2.5.1.3.7. Rest of Asia Pacific
    - 5.2.5.1.4. Middle East & Africa
      - 5.2.5.1.4.1. UAE
      - 5.2.5.1.4.2. Saudi Arabia
      - 5.2.5.1.4.3. South Africa
      - 5.2.5.1.4.4. Rest of MEA
    - 5.2.5.1.5. South America
      - 5.2.5.1.5.1. Argentina
      - 5.2.5.1.5.2. Brazil
      - 5.2.5.1.5.3. Rest of South America

Chapter 6. North America Microalgae Biotechnology Market Analysis

6.1. Key Insights
6.2. Market Size and Forecast, 2020-2035 (US$ Mn)
- 6.2.1. By Product Type
- 6.2.2. By Application
- 6.2.3. By Technology
- 6.2.4. By End User
- 6.2.5. By Country

Chapter 7. Europe Microalgae Biotechnology Market Analysis

7.1. Key Insights
7.2. Market Size and Forecast, 2020-2035 (US$ Mn)
- 7.2.1. By Product Type
- 7.2.2. By Application
- 7.2.3. By Technology
- 7.2.4. By End User
- 7.2.5. By Country

Chapter 8. Asia Pacific Microalgae Biotechnology Market Analysis

8.1. Key Insights
8.2. Market Size and Forecast, 2020-2035 (US$ Mn)
- 8.2.1. By Product Type
- 8.2.2. By Application
- 8.2.3. By Technology
- 8.2.4. By End User
- 8.2.5. By Country

Chapter 9. Middle East & Africa Microalgae Biotechnology Market Analysis

9.1. Key Insights
9.2. Market Size and Forecast, 2020-2035 (US$ Mn)
- 9.2.1. By Product Type
- 9.2.2. By Application
- 9.2.3. By Technology
- 9.2.4. By End User
- 9.2.5. By Country

Chapter 10. South America Microalgae Biotechnology Market Analysis

10.1. Key Insights
10.2. Market Size and Forecast, 2020-2035 (US$ Mn)
- 10.2.1. By Product Type
- 10.2.2. By Application
- 10.2.3. By Technology
- 10.2.4. By End User
- 10.2.5. By Country